ClinicalTrials.Veeva

Menu

Effect of FFR Guided Percutaneous Coronary Intervention in Coronary Tandem Lesions (IRISFFRTandem)

S

Seung-Jung Park

Status

Enrolling

Conditions

Percutaneous Transluminal Coronary Angioplasty

Treatments

Other: 5 year Follow-up

Study type

Observational

Funder types

Other

Identifiers

NCT02797561
AMCCV2016-12

Details and patient eligibility

About

The purpose of this study is to evaluate the effect of FFR (Fractional flow reserve) guided Percutaneous Coronary Intervention in coronary tandem lesions.

Enrollment

1,000 estimated patients

Sex

All

Ages

19+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Tandem lesion evaluated by FFR
  • Written consent

Exclusion criteria

  • TIMI flow < 3
  • Grafted vessel
  • Left ventricular ejection fraction < 30%
  • Severe calcification and/or severe tortuosity
  • Uncontrolled coronary spasm
  • Life expectancy < 2 years
  • Planned high risk surgery
  • Pregnancy or breast-feeding

Trial design

1,000 participants in 1 patient group

Tandem lesion evaluated by FFR
Treatment:
Other: 5 year Follow-up

Trial contacts and locations

14

Loading...

Central trial contact

Seung-jung Park, MD; Jung-hee Ham, Project leader

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems